Notice of Lodging of Proposed Material Modification to Consent Decree Under the Clean Water Act, 26930-26931 [2024-07935]
Download as PDF
<![CDATA[
khammond on DSKJM1Z7X2PROD with NOTICES
26930
Federal Register / Vol. 89, No. 74 / Tuesday, April 16, 2024 / Notices
Scottdale, AZ; Florida Institute for
Human & Machine Cognition, Inc.,
Pensacola, FL; GaitIQ, Inc., San
Antonio, TX; GelSana Therapeutics,
Inc., Aurora, CO; GeneInfoSec, Boulder,
CO; Gener8 LLC, San Jose, CA;
Georgetown University, Washington,
DC; Ginkgo Bioworks, Inc., Boston, MA;
Glendor, Inc., Draper, UT; Grant
Halliburton Foundation, Inc., Dallas,
TX; Gwen Lily Research Foundation,
Irving, TX; Harmony Healthcare
Solutions, Inc. dba Harmony Health,
Sunnyvale, CA; Healthpointe Solutions,
Inc., Austin, TX; HERMTAC LLC,
Dallas, TX; ICON Government and
Public Health Solutions, Inc., Blue Bell,
PA; Inhance Digital Corp., Los Angeles,
CA; Innovation Incubator, Inc., Bayside,
NY; International Business Machines
Corp., Armonk, NY; INVIZA Corp.,
Malden, MA; IOTAI, Inc., Fremont, CA;
Irrational Labs, Oakland, CA; Irving
Burton Associates, Silver Springs, MD;
JPS Health Network, Fort Worth, TX;
Jubilant Hollisterstier LLC, Spokane,
WA; Jurata Thin Film, Inc., Chapel Hill,
NC; K2 Biolabs, Inc., Houston, TX;
Kaibab Health, Sheridan, WY; Knight
Technical Solutions LLC, Huntsville,
AL; Lazarus 3D, Philomath, OR;
Lighthouse XR LLC, Chester, VA; Limax
Biosciences, Inc., Somerville, MA;
Locus Biosciences, Morrisville, NC; LSU
Health Science Center: New Orleans,
New Orleans, LA; LSU Health
Shreveport, Shreveport, LA; Luna Labs
USA LLC, Charlottesville, VA; M3D,
Inc., Ann Arbor, MI; MapHabit, Inc.,
Atlanta, GA; Maravai Lifesciences, San
Diego, CA; Maryland Technology
Development Corp., Columbia, MD;
Mass General Brigham, Somerville, MA;
Maxwell Biosciences, Inc., Austin, TX;
MDC Studio, Inc., Baltimore, MD;
Medable, Palo Alto, CA; MedVector, El
Segundo, CA; Memsel, Inc., Fort Worth,
TX; Moberg Analytics, Inc.,
Philadelphia, PA; Molecular
Technologies Laboratories LLC,
Columbus, OH; MRIGlobal,
Gaithersburg, MD; National Association
of Community Health Centers, Inc.,
Bethesda, MD; National Hispanic Health
Foundation, Washington, DC; National
Resilience, Inc., San Diego, CA; National
Strategic Research Institute, Omaha, NE;
Neurxstem, Inc., Columbus, OH; New
Horizons Diagnostics Corp., Baltimore,
MD; NIRSense, Inc., Richmond, VA;
North Carolina State University,
Raleigh, NC; NXTech, Inc., Patchogue,
NY; O3 World LLC, Philadelphia, PA;
Oceanit Laboratories, Inc., Honolulu, HI;
OLSF Ventures, Tulsa, OK; Oregon
Bioscience Association, Portland, OR;
Orlando Health, Orlando, FL; Otter Cove
Solutions LLC, Gaithersburg, MD; OXOS
VerDate Sep<11>2014
19:09 Apr 15, 2024
Jkt 262001
Medical, Atlanta, GA; Parkland Center
for Clinical Innovation, Dallas, TX;
Parkland Health, Dallas, TX; Patchwise
Labs, Alameda, CA; Pennington
Biomedical Research Center, Baton
Rouge, LA; Pennsylvania State
University—College of Medicine,
Hershey, PA; Phronetik, Inc., Flower
Mound, TX; Polaris Sensor
Technologies, Inc., Huntsville, AL; PPD
Development LP, Wilmington, NC;
ppxTEX LLC, Jackson, MS; PragmaClin,
St. John’s, CANADA; PriMetaz, Boston,
MA; Proteios Technology, Inc.,
Issaquah, WA; Purdue University, West
Lafayette, IN; Qana Therapeutics, Inc.,
Austin, TX; QuantaSpec, Inc., Essex
Junction, VT; Re:Build Manufacturing,
Framingham, MA; Research Your Health
LLC, Plano, TX; Resonantia Diagnostics,
Inc., Dallas, TX; Ridgeline Therapeutics,
Houston, TX; Ronawk, Inc., Overland
Park, KS; Rubitection, Pittsburgh, PA;
Rubix LS, Lawrence, MA; Rutgers
University, New Brunswick, NJ;
Safebeat Rx, Inc., Carson, CA; SafeGuard
Surgical, Tampa, FL; SafetySpect, Inc.,
Grand Forks, ND; Safi Biotherapeutics,
Inc., Cambridge, MA; SanaHeal, Inc.,
Boston, MA; Scorpius
BioManufacturing, San Antonio, TX;
Signature Science LLC, Austin, TX;
Signum Technologies, Inc., Randor, PA;
SimX, Inc., San Francisco, CA; Sonera
Magentics, Inc., Berkeley, CA;
Southwest Research Institute, San
Antonio, TX; Southwest Texas Regional
Advisory Council, San Antonio, TX;
Sozo Dx LLC, Plano, TX; Sparta Science,
San Francisco, CA; SPEAR Human
Performance, Inc., Tallahassee, FL;
Spectral Platforms, Duarte, CA; Sperry
Medtech, Inc., Springfield, MA;
Stanford Byers Center for Biodesign,
Stanford, CA; Stellarray, Inc., Austin,
TX; Swaza, Mountain View, CA; Talis
Biomedical Corp., Redwood City, CA;
Texas A&M Engineering Experiment
Station, Bryan, TX; Texas Biomedical
Research Institute, San Antonio, TX;
Texas Healthcare and Bioscience
Institute, Austin, TX; Texas Oncology,
Dallas, TX; Texas State University—
Translational Health Research Center,
San Marcos, TX; Texas Tech University
Health Sciences Center, Lubbock, TX;
Texas Woman’s University, Denton, TX;
The Geneva Foundation, Tacoma, WA;
The Henry M. Jackson Foundation for
the Advancement of Military Medicine,
Bethesda, MD; The Life Raft Group,
Wayne, NJ; The Nebraska Medical
Center, Omaha, NE; The University of
Texas at Dallas, Richardson, TX; The
University of Texas: M.D Anderson
Cancer Center, Houston, TX; TheraTec,
Inc., Horace, ND; TheraVista Health,
Brentwood, TN; Thomas Jefferson
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
University, Philadelphia, PA;
Tranexamic Technologies LLC, Dallas,
TX; Ubiros, Inc., Natick, MA; University
City Science Center, Philadelphia, PA;
University of California at Riverside,
Riverside, CA; University of Delaware,
Newark, DE; University of Hawai’i
System, Honolulu, HI; University of
Montana, Missoula, MT; University of
Nebraska Medical Center, Omaha, NE;
University of Notre Dame, Notre Dame,
IN; University of Southern California,
Los Angeles, CA; University of Texas at
Austin, Austin, TX; University of Texas
at San Antonio, San Antonio, TX;
Univox Technical Solutions LLC dba
Univox LLC, Tijeras, NM; Vanderbilt
University, Nashville, TN; Varda Space
Industries, Inc., El Segundo, CA;
VelocityTX, San Antonio, TX; Verily
Life Sciences LLC, South San Francisco,
CA; ViBo Health, Fairfax, VA; Vivonics,
Inc., Bedford, MA; Wake Forest
University Health Sciences, Winston
Salem, MA; Weinberg Medical Physics,
Inc., Rockville, MD; West-Tech
Materials, Keller, TX; Yuzu Labs Public
Benefit Corp., San Francisco, CA; Zeteo
Biomedical LLC, Austin, TX; Zeteo
Tech, Inc., Sykesville, MD; Zymeron
Corp., Durham, NC.
Consistent with 15 U.S.C.
4301(a)(6)(C), (E) and (F), the CX Hub is
a new consortium created in response to
requirements of the Advanced Research
Projects Agency for Health (ARPA–H)
for the active transition of health
innovation in an expedient, safe, costeffective, accessible, and sustainable
manner that reaches all Americans. The
CX Hub will take a human-centered
approach to develop technologies and
health solutions that will be accessible,
desirable, and affordable for all. It will
also take a proactive approach to
enhance clinical trials, reach
representative patient populations, and
capture outcomes data for future use
leading to better and more equitable
health outcomes for all.
Suzanne Morris,
Deputy Director Civil Enforcement
Operations, Antitrust Division.
[FR Doc. 2024–07942 Filed 4–15–24; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed Material
Modification to Consent Decree Under
the Clean Water Act
On April 10, 2024, the Department of
Justice lodged a proposed material
modification to a Consent Decree
(‘‘Decree’’) with the United States
District Court for the Eastern District of
Kentucky in the lawsuit entitled United
E:\FR\FM\16APN1.SGM
16APN1
Federal Register / Vol. 89, No. 74 / Tuesday, April 16, 2024 / Notices
States and Commonwealth of Kentucky
v. Lexington-Fayette Urban County
Government, Civil Action No. 5:06–cv–
386–KSF.
The Consent Decree—entered by the
court in 2011—resolved alleged
violations of the Clean Water Act
stemming from Lexington-Fayette Urban
County Government’s (‘‘LFUCG’’)
operation of its sanitary sewer system
and wastewater treatment plant. The
Decree—including a First Material
Modification entered by the court in
2015—required LFUCG to complete
remedial projects to its sewer system
and wastewater treatment plant to
eliminate sanitary sewer overflows by
December 31, 2026. The proposed
material modification extends the final
compliance deadline for remedial
projects by four years to December 31,
2030, as well as making changes to
reporting frequency and methods.
The publication of this notice opens
a period for public comment on the
proposed modification. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States and
Commonwealth of Kentucky v.
Lexington-Fayette Urban County
Government, D.J. Ref. No. 90–5–1–1–
08858. All comments must be submitted
no later than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
khammond on DSKJM1Z7X2PROD with NOTICES
By mail .........
During the public comment period,
the proposed modification, along with
the previously entered Consent Decree
and First Material Modification, may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
If you require assistance accessing the
proposed material modification, you
may request assistance by email or by
mail to the addresses provided above for
submitting comments.
Scott D. Bauer,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2024–07935 Filed 4–15–24; 8:45 am]
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Safe
Drinking Water Act
On April 9, 2024, the Department of
Justice lodged a proposed Consent
Decree with the United States District
Court for the Eastern District of
California in the lawsuit entitled United
States v. Grindstone Indian Rancheria
of Wintun-Wailaki Indians of California,
Civil Action No. 2:24–cv–01044–KJM–
CKD.
The proposed Consent Decree would
resolve claims against the Grindstone
Indian Rancheria of Wintun-Wailaki
Indians of California (‘‘Defendant’’)
arising under sections 1414(g) and 1431
of the Safe Drinking Water Act
(‘‘SDWA’’), 42 U.S.C. 300g–3(g) and
300i, and the SDWA’s National Primary
Drinking Water Regulations at 40 CFR
part 141, as well as for its failure to
comply with the requirements of two
administrative orders issued by the
United States Environmental Protection
Agency pertaining to Defendant’s
noncompliance with the SDWA and its
regulations at the Grindstone Indian
Rancheria Public Water System. The
proposed Consent Decree resolves these
claims and includes a civil penalty of
$8,963 and injunctive relief including,
but not limited to, demonstrating
compliance with surface water
treatment requirements, providing boil
water notices and alternative water
supply, retaining at least two full time
operators for the drinking water system,
providing annual reporting to its
customers, providing operating reports
to EPA, and developing and
implementing an extensive operation
and maintenance plan for the water
system.
The publication of this notice opens
a period for public comment on the
proposed Consent Decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States v. Grindstone
Indian Rancheria of Wintun-Wailaki
Indians of California, D.J. Ref. No. 90–
5–1–1–12322. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
BILLING CODE 4410–15–P
VerDate Sep<11>2014
19:09 Apr 15, 2024
Jkt 262001
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
26931
To submit
comments:
Send them to:
By mail .........
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
Any comments submitted in writing
may be filed by the United States in
whole or in part on the public court
docket without notice to the commenter.
During the public comment period,
the proposed Consent Decree may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
If you require assistance accessing the
proposed Consent Decree, you may
request assistance by email or by mail
to the addresses provided above for
submitting comments.
Scott Bauer,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2024–07926 Filed 4–15–24; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the
Comprehensive Environmental
Response, Compensation, and Liability
Act
On April 11, 2024, the Department of
Justice lodged a proposed consent
decree with the United States District
Court for the District of New Jersey in
the lawsuit entitled United States, New
Jersey Department of Environmental
Protection, the Commissioner of the
New Jersey Department of
Environmental Protection, and the
Administrator of the New Jersey Spill
Compensation Fund v. PPG Industries,
Inc., Civil Action No. 2:24–04771.
The United States filed this lawsuit
under the Comprehensive
Environmental Response,
Compensation, and Liability Act
(‘‘CERCLA’’), on behalf of the U.S.
Environmental Protection Agency
(‘‘EPA’’). The New Jersey Department of
Environmental Protection, the
Commissioner of the New Jersey
Department of Environmental
Protection, and the Administrator of the
New Jersey Spill Compensation Fund
(collectively, ‘‘NJDEP’’) are co-plaintiffs.
PPG Industries, Inc. (‘‘PPG’’) is the
defendant named in the complaint. The
complaint seeks injunctive relief and
reimbursement of response costs in
connection with the Riverside Industrial
E:\FR\FM\16APN1.SGM
16APN1
]]>Agencies
[Federal Register Volume 89, Number 74 (Tuesday, April 16, 2024)]
[Notices]
[Pages 26930-26931]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07935]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed Material Modification to Consent
Decree Under the Clean Water Act
On April 10, 2024, the Department of Justice lodged a proposed
material modification to a Consent Decree (``Decree'') with the United
States District Court for the Eastern District of Kentucky in the
lawsuit entitled United
[[Page 26931]]
States and Commonwealth of Kentucky v. Lexington-Fayette Urban County
Government, Civil Action No. 5:06-cv-386-KSF.
The Consent Decree--entered by the court in 2011--resolved alleged
violations of the Clean Water Act stemming from Lexington-Fayette Urban
County Government's (``LFUCG'') operation of its sanitary sewer system
and wastewater treatment plant. The Decree--including a First Material
Modification entered by the court in 2015--required LFUCG to complete
remedial projects to its sewer system and wastewater treatment plant to
eliminate sanitary sewer overflows by December 31, 2026. The proposed
material modification extends the final compliance deadline for
remedial projects by four years to December 31, 2030, as well as making
changes to reporting frequency and methods.
The publication of this notice opens a period for public comment on
the proposed modification. Comments should be addressed to the
Assistant Attorney General, Environment and Natural Resources Division,
and should refer to United States and Commonwealth of Kentucky v.
Lexington-Fayette Urban County Government, D.J. Ref. No. 90-5-1-1-
08858. All comments must be submitted no later than thirty (30) days
after the publication date of this notice. Comments may be submitted
either by email or by mail:
------------------------------------------------------------------------
To submit comments: Send them to:
------------------------------------------------------------------------
By email............................ [email protected].
By mail............................. Assistant Attorney General, U.S.
DOJ--ENRD, P.O. Box 7611,
Washington, DC 20044-7611.
------------------------------------------------------------------------
During the public comment period, the proposed modification, along
with the previously entered Consent Decree and First Material
Modification, may be examined and downloaded at this Justice Department
website: https://www.justice.gov/enrd/consent-decrees. If you require
assistance accessing the proposed material modification, you may
request assistance by email or by mail to the addresses provided above
for submitting comments.
Scott D. Bauer,
Assistant Section Chief, Environmental Enforcement Section, Environment
and Natural Resources Division.
[FR Doc. 2024-07935 Filed 4-15-24; 8:45 am]
BILLING CODE 4410-15-P
